McMaster Researchers Trace Statin Muscle Damage in 7%-29% of Users to Immune Trigger
Updated
Updated · SciTechDaily · Jul 13
McMaster Researchers Trace Statin Muscle Damage in 7%-29% of Users to Immune Trigger
2 articles · Updated · SciTechDaily · Jul 13
Summary
McMaster researchers found statins can disrupt muscle-cell energy production, creating metabolic stress that then activates immune signaling and drives inflammation and tissue injury.
Cell and mouse experiments showed that blocking that immune response prevented much of the damage, suggesting the muscle side effect is not an unavoidable result of lowering cholesterol.
The finding matters because muscle symptoms affect an estimated 7% to 29% of statin users and can push high-risk patients to cut doses or stop treatment altogether.
Science Advances published the study on June 19, and the team said the pathway offers drug targets that could ease statin intolerance without weakening cardiovascular benefits.
Statins cause muscle pain by triggering the immune system. Is a therapy that blocks this side effect finally within reach?
A new calculator predicts serious statin side effects. Will this tool change how millions receive this life-saving medication?
Statins and Muscle Damage: 2026 Study Reveals Immune Pathway, Prevalence, and Next Steps for Patients
Overview
A major study from McMaster University in June 2026 revealed how statins, common cholesterol-lowering drugs, can cause muscle pain and weakness. The research showed that statins disrupt energy production in muscle cells, leading to metabolic stress. This stress then triggers a strong immune response in the muscle, causing inflammation and tissue injury, which results in the muscle symptoms many patients experience. Importantly, the study found that blocking this immune response can prevent much of the muscle damage. This new understanding could help develop treatments that keep the benefits of statins while reducing their muscle side effects.